Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)

HKG:1501 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	480.21	521.95	423.67	518.27	640.55	870.13
Short-Term Investments	24.84	-	10.73	10	-	-
Trading Asset Securities	-	30	-	-	-	71.45
Cash & Short-Term Investments	505.05	551.95	434.4	528.27	640.55	941.59
Cash Growth	39.11%	27.06%	-17.77%	-17.53%	-31.97%	-11.02%
Accounts Receivable	85.86	115.07	122.92	71.38	78.67	23.66
Other Receivables	6.22	3.81	2.27	2.7	0.91	0.54
Receivables	92.09	118.88	125.19	74.08	79.58	24.19
Inventory	197.46	162.34	128.77	154.28	92.49	55.21
Other Current Assets	74.74	58.96	35.93	45.32	45.81	27.14
Total Current Assets	869.34	892.13	724.29	801.94	858.44	1,048
Property, Plant & Equipment	957.56	916.66	898.28	749.61	564.97	300.17
Long-Term Investments	277.8	199.31	206.47	162.45	130.17	49.06
Other Intangible Assets	422.78	168.74	130.37	7.16	6.42	5.99
Long-Term Deferred Tax Assets	28.53	30.37	17.65	15.04	9.46	2.15
Long-Term Deferred Charges	-	-	-	62.77	21.46	1.61
Other Long-Term Assets	15.01	52.67	52.56	28.37	30.63	15.58
Total Assets	2,877	2,260	2,030	1,827	1,622	1,423
Accounts Payable	78.28	44.32	33.03	36.41	26.99	16.02
Accrued Expenses	45.48	45.91	40.87	37.12	18.92	13.02
Short-Term Debt	373.47	227.26	79.12	32.68	-	-
Current Portion of Leases	9.27	0.9	-	0.2	0.19	0.32
Current Income Taxes Payable	14.93	21.51	22.42	12.6	12.22	8.18
Current Unearned Revenue	26.75	21.04	38.62	66.8	36.11	14.8
Other Current Liabilities	147.36	73.52	102.76	53.85	58.8	35.97
Total Current Liabilities	695.54	434.46	316.83	239.67	153.22	88.31
Long-Term Leases	21.65	15.52	15.66	15.94	13.21	1.41
Long-Term Unearned Revenue	21.99	23.41	16.99	10.95	13.7	5.31
Long-Term Deferred Tax Liabilities	13.11	-	1.77	6.67	3.5	-
Total Liabilities	917.75	473.39	351.25	273.23	183.63	95.04
Common Stock	176	176	171	168	166	166
Retained Earnings	750.83	652.3	507.5	391.36	303.33	207.68
Treasury Stock	-40.18	-40.18	-21.26	-	-	-
Comprehensive Income & Other	989.25	986.11	992	952.65	926.14	931.97
Total Common Equity	1,876	1,774	1,649	1,512	1,395	1,306
Minority Interest	83.47	12.27	29.14	42.09	42.45	22
Shareholders' Equity	1,959	1,786	1,678	1,554	1,438	1,328
Total Liabilities & Equity	2,877	2,260	2,030	1,827	1,622	1,423
Total Debt	569.86	243.69	94.78	48.83	13.4	1.73
Net Cash (Debt)	-64.8	308.27	339.62	479.44	627.15	939.85
Net Cash Growth	-	-9.23%	-29.16%	-23.55%	-33.27%	-11.03%
Net Cash Per Share	-0.38	1.81	1.99	2.84	3.76	5.66
Filing Date Shares Outstanding	175.2	175.2	170.11	168	166	166
Total Common Shares Outstanding	175.2	175.2	170.11	168	166	166
Working Capital	173.8	457.68	407.46	562.28	705.22	959.8
Book Value Per Share	10.71	10.13	9.70	9.00	8.41	7.87
Tangible Book Value	1,147	1,605	1,519	1,505	1,389	1,300
Tangible Book Value Per Share	6.55	9.16	8.93	8.96	8.37	7.83
Buildings	-	518.29	425.78	61.2	43.52	43.52
Machinery	-	348.95	297.7	219	171.07	119.58
Construction In Progress	-	1.94	89.86	386.1	286.09	61.62
Leasehold Improvements	-	156.38	122.8	83.41	46.57	42.45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.